Investor Short Report Flags Steep Downside Risk For iRhythm Technologies (CORRECTED)

All NewsAugust 20, 2025

Spruce Point Capital warned iRhythm Technologies could face a 40%–70% stock decline, citing regulatory risks and product safety issues.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent